Altered podocyte structure in GLEPP1 (Ptpro)-deficient mice associated with hypertension and low glomerular filtration rate
about
Disruption of PTPRO causes childhood-onset nephrotic syndromeGLEPP1/protein-tyrosine phosphatase phi inhibitors block chemotaxis in vitro and in vivo and improve murine ulcerative colitisMethylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemiaAnuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxinPodocytesGenes and podocytes - new insights into mechanisms of podocytopathyFyn binds to and phosphorylates the kidney slit diaphragm component NephrinInsight into podocyte differentiation from the study of human genetic disease: nail-patella syndrome and transcriptional regulation in podocytesAntibodies to protein tyrosine phosphatase receptor type O (PTPro) increase glomerular albumin permeability (P(alb))Expression of PTPRO in the interneurons of adult mouse olfactory bulbProtein tyrosine phosphatase receptor type O regulates development and function of the sensory nervous system.Three-dimensional electron microscopy reveals the evolution of glomerular barrier injury.The glomerular transcriptome and a predicted protein-protein interaction network.Actin-depolymerizing factor cofilin-1 is necessary in maintaining mature podocyte architectureEpigenetic regulation of protein tyrosine phosphatases: potential molecular targets for cancer therapy.Reduced glomerular epithelial protein 1 expression and podocyte injury in immunoglobulin A nephropathy.Genetic causes of proteinuria and nephrotic syndrome: impact on podocyte pathobiology.Decreased nephrin and GLEPP-1, but increased VEGF, Flt-1, and nitrotyrosine, expressions in kidney tissue sections from women with preeclampsiaIncreased SHP-1 protein expression by high glucose levels reduces nephrin phosphorylation in podocytesProtein tyrosine phosphatases as drug targets: PTP1B and beyond.Candidate genes in quantitative trait loci associated with absolute and relative kidney weight in rats with Inherited Stress Induced Arterial Hypertension.Glomerular proteinuria: a complex interplay between unique players.Identification of the nephropathy-susceptibility locus HIVAN4Podocyte Protein, Nephrin, Is a Substrate of Protein Tyrosine Phosphatase 1BReview series: The cell biology of renal filtration.PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse modelCRYP-2/cPTPRO is a neurite inhibitory repulsive guidance cue for retinal neurons in vitroTargeting the PTPome in human disease.Protein-tyrosine phosphatases and cancer.Molecular regulation of kidney development.Protein tyrosine phosphatase receptor type O inhibits trigeminal axon growth and branching by repressing TrkB and Ret signaling.Protein tyrosine phosphatase receptor type O (Ptpro) regulates cerebellar formation during zebrafish development through modulating Fgf signaling.Protein tyrosine phosphatases: functional inferences from mouse models and human diseases.Linkage analysis of glomerular filtration rate in American Indians.Targeted transgenic expression of an osteoclastic transmembrane protein-tyrosine phosphatase in cells of osteoclastic lineage increases bone resorption and bone loss in male young adult mice.Role of protein-tyrosine phosphatases in regulation of osteoclastic activity.A compendium of urinary biomarkers indicative of glomerular podocytopathy.PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapyTyrosine kinase signaling in kidney glomerular podocytes.The glomerular filtration barrier: components and crosstalk
P2860
Q24309282-FC858D27-FB83-49AD-84D7-52F33E012237Q24313112-02FC19DE-86D9-4F17-92A5-50A8B0C74A44Q24619893-F29F88DB-FFC7-4D2E-A5F4-DE7A030AC4CDQ24675668-C311331E-2167-4D92-90DA-F6328C277964Q26766118-ED203B47-A0BA-412B-9241-2C7575D9C74BQ26866422-8D85E6B6-BCE2-48A0-BAB9-49F44CDD4C55Q28187793-009A0FF0-2C47-4CCD-958A-602F44D02B0DQ28215959-360A04E5-9A7A-410A-8C8B-92EAE7C7D3D2Q28572714-38A61A3B-C90E-449D-B4BC-B48E711E4FB6Q28589064-B43505B8-8AD6-4E6B-A9EA-B638AE95BAB5Q28593226-A947E734-1F80-46C7-8F7C-B0A822F97BF8Q30820232-D0076D47-EED3-4518-BBD8-A3BC754A2334Q33306795-71C90FD0-3D9E-40E9-94A0-EC239BC3AC18Q33991246-B1FCA7A7-07B2-4981-9A75-8236EA80442DQ34528296-652044C7-A70E-47C2-AF04-9899CF9FC52DQ34642039-2F1BB313-74A1-4EB7-9802-CB78645F271FQ34674987-1E848309-62D2-45A1-B499-0CA6C65FAD69Q34731351-D2EC52AB-B5E4-4822-B857-955440685264Q34801482-2853A3D2-A798-41D9-AA6B-BE25E8FAB4D6Q35020553-F515A013-8A82-4B8D-944F-8335EA6E7FE0Q35093174-16F17769-C314-493A-9BDF-E75825CC076BQ35131205-5AFED33D-CCE1-41AA-A826-7638E189665CQ35142721-FBA1A36B-E160-423D-A049-34E210830820Q35369499-150C3D3E-54A5-4168-B368-6D401463CC26Q35543167-9615D60D-A403-410E-8C06-D06BCEFFA35DQ35685290-D9F84705-00AE-4E26-B41C-29649FE41E19Q36377653-BA69A34D-EC71-4472-866B-0F6DF4FF024FQ36379394-80B34C02-7777-49C2-B403-4F79C44AB446Q36430193-A16341F8-ED27-4936-924C-5948D0D3024CQ36737769-C3D2FB18-3755-4F3B-9153-859ED998AEC5Q36886953-972FCFCF-C452-4BC4-B1AC-9BF14021D6C5Q36913455-AA5D4EB0-5364-43DE-80EB-C1DAD9D540CDQ37094061-32C25BC5-02E0-4E0B-9B90-9C627295B68BQ37117112-0571E796-2BB9-4A0B-91E1-6CAA1AAA6DCBQ37160930-137D3425-D011-4BA5-A591-C36397E4A077Q37263070-FEB35CB4-D25E-40F8-85BE-1108157BADD0Q37353481-A189CB0F-AE62-4829-B045-D0CB212CB4E4Q37367387-BBFDE417-92FD-468E-A64E-04800821AA88Q37903259-EB75F486-0B2D-4BE7-9456-F029CF9B7BE6Q38039100-FE2AEDF0-B2FC-41C2-BD07-9C73128B99D6
P2860
Altered podocyte structure in GLEPP1 (Ptpro)-deficient mice associated with hypertension and low glomerular filtration rate
description
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2000
@ast
im November 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2000/11/01)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/11/01)
@nl
наукова стаття, опублікована в листопаді 2000
@uk
مقالة علمية (نشرت في نوفمبر 2000)
@ar
name
Altered podocyte structure in ...... low glomerular filtration rate
@ast
Altered podocyte structure in ...... low glomerular filtration rate
@en
Altered podocyte structure in ...... low glomerular filtration rate
@nl
type
label
Altered podocyte structure in ...... low glomerular filtration rate
@ast
Altered podocyte structure in ...... low glomerular filtration rate
@en
Altered podocyte structure in ...... low glomerular filtration rate
@nl
prefLabel
Altered podocyte structure in ...... low glomerular filtration rate
@ast
Altered podocyte structure in ...... low glomerular filtration rate
@en
Altered podocyte structure in ...... low glomerular filtration rate
@nl
P2093
P2860
P3181
P356
P1476
Altered podocyte structure in ...... low glomerular filtration rate
@en
P2093
B L Wharram
D B Kershaw
J E Wiggins
L B Holzman
L C Samuelson
P J Gillespie
R C Wiggins
P2860
P304
P3181
P356
10.1172/JCI7236
P407
P577
2000-11-01T00:00:00Z